Institutional Manager · CIK 0001017645
GENERAL ATLANTIC, L.P.
New York, NY · File #028-03473
Latest AUM
$2.87B
Positions
13
Top-10 Concentration
99.0%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | AKERO THERAPEUTICS | 00973Y108 | -5,733,989 | -$272.2M | $0 |
| REDUCE | ALIGNMENT HEALTHCARE | ALHC | -11,119,494 | -$219.6M | +$55.9M |
| NEW | NURIX THERAPEUTICS | NRIX | +4,897,159 | +$92.9M | $0 |
| REDUCE | CENTESSA PHARMACEUTICALS | CNTA | -3,564,103 | -$89.1M | +$7.4M |
| REDUCE | WEBULL | BULLW | -7,148,051 | -$55.5M | -$50.5M |
| EXITED | ROYALTY PHARMA | G7709Q104 | -1,500,000 | -$52.9M | $0 |
| ADD | CHIME | 16935C109 | +2,050,923 | +$51.6M | +$96.0M |
| REDUCE | XP, INC | XP | -2,818,600 | -$46.1M | -$61.8M |
| ADD | REVOLUTION MEDICINES | RVMDW | +338,500 | +$27.0M | +$81.5M |
| EXITED | ADAGENE | 005329107 | -3,782,339 | -$7.5M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202513 pos · $2.87B
- 13F HOLDINGS REPORTQ/E Sep 202516 pos · $3.33B
- 13F HOLDINGS REPORTQ/E Jun 202515 pos · $3.63B
- 13F HOLDINGS REPORTQ/E Mar 202515 pos · $2.98B
- 13F HOLDINGS REPORTQ/E Dec 202416 pos · $2.81B
- 13F HOLDINGS REPORTQ/E Sep 202418 pos · $3.52B
- 13F HOLDINGS REPORTQ/E Jun 202419 pos · $3.18B
- 13F HOLDINGS REPORTQ/E Mar 202422 pos · $4.31B
- 13F HOLDINGS REPORTQ/E Dec 202329 pos · $6.48B
Top 13 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | DLOCAL | DLO | 46,656,695 | $659.7M | 22.97% |
| 2 | CHIME | 16935C109 | 21,259,683 | $535.1M | 18.63% |
| 3 | XP, INC | XP | 22,699,133 | $371.6M | 12.93% |
| 4 | ALKAMI | ALKT | 11,991,480 | $276.6M | 9.63% |
| 5 | ALIGNMENT HEALTHCARE | ALHC | 13,167,733 | $260.1M | 9.05% |
| 6 | REVOLUTION MEDICINES | RVMDW | 2,812,928 | $224.0M | 7.80% |
| 7 | PHARVARIS | PHVS | 8,031,252 | $222.9M | 7.76% |
| 8 | CENTESSA PHARMACEUTICALS | CNTA | 6,117,715 | $153.0M | 5.33% |
| 9 | NURIX THERAPEUTICS | NRIX | 4,897,159 | $92.9M | 3.23% |
| 10 | EUROPEAN WAX CENTER | 29882P106 | 13,110,492 | $47.2M | 1.64% |
| 11 | RISKIFIED | RSKD | 5,324,998 | $26.5M | 0.92% |
| 12 | GROVE COLLABORATIVE | GROVW | 2,474,859 | $2.7M | 0.09% |
| 13 | WEBULL | BULLW | 50,816 | $394,840 | 0.01% |